Search

Your search keyword '"Institut Gustave Roussy (IGR)"' showing total 3,735 results

Search Constraints

Start Over You searched for: Author "Institut Gustave Roussy (IGR)" Remove constraint Author: "Institut Gustave Roussy (IGR)"
3,735 results on '"Institut Gustave Roussy (IGR)"'

Search Results

201. Low Doses of Radiation Increase the Immunosuppressive Profile of Lung Macrophages During Viral Infection and Pneumonia

202. Exploring the contribution of the mitochondrial disulfide relay system to Parkinson’s disease: the PINK1/CHCHD4 interplay

203. NIVOREN GETUG-AFU 26 translational study: Baseline peripheral cytokines predict survival in metastatic clear cell renal carcinoma (RCC) treated with nivolumab

204. Screening for SARS-CoV-2 by RT-PCR: Saliva or nasopharyngeal swab? Rapid review and meta-analysis

205. Influence of the microenvironment on modulation of the host response by typhoid toxin

206. Efficacy, safety and factors associated with disease progression in patients with unresectable (stage III) or distant metastatic (stage IV) BRAF V600-mutant melanoma: An open label, non-randomized, phase IIIb study of trametinib in combination with dabrafenib

207. Clinical and molecular analysis of smoothened inhibitors in Sonic Hedgehog medulloblastoma

208. Multiethnic genome-wide association study of differentiated thyroid cancer in the EPITHYR consortium

209. PBRM1 Deficiency Confers Synthetic Lethality to DNA Repair Inhibitors in Cancer

210. Human leukocyte antigen (HLA) class I/II expression as a predictive biomarker for response to immune oncology (IO) therapy in metastatic clear-cell renal cell carcinoma (m-ccRCC)

211. Cardiac Metastasis from Medullary Thyroid Cancers with Long-Term Survival under Vandetanib

212. Harnessing subcellular-resolved organ distribution of cationic copolymer-functionalized fluorescent nanodiamonds for optimal delivery of therapeutic siRNA to a xenografted tumor in mice

213. Serial transplantation unmasks galectin-9 contribution to tumor immune escape in the MB49 murine model

214. SparseConvMIL: Sparse Convolutional Context-Aware Multiple Instance Learning for Whole Slide Image Classification

215. Patient external dose rate after 177Lu-DOTATATE therapy: factors affecting its decrease and predictive value

216. Clinical practice guidelines for BRCA1 and BRCA2 genetic testing

217. AI-driven quantification, staging and outcome prediction of COVID-19 pneumonia

218. Identification of biallelic germline variants of SRP68 in a sporadic case with severe congenital neutropenia

219. Ketogenic diet and ketone bodies enhance the anticancer effects of PD-1 blockade

220. Machine-Learning-Based Radiomics MRI Model for Survival Prediction of Recurrent Glioblastomas Treated with Bevacizumab

221. Rare germline pathogenic variants identified by multigene panel testing and the risk of aggressive prostate cancer

222. PD-L1 testing in urothelial bladder cancer: essentials of clinical practice

223. NADPH oxidase DUOX1 sustains TGF-β1 signalling and promotes lung fibrosis

224. Serial transplantation unmasks galectin-9 contribution to tumor immune escape in the MB49 murine model

225. Trend of antibiotic consumption and its association with influenza-like illnesses in France between 2004 and 2018

226. Onyx injection by direct puncture for presurgical embolization of a C2 hypervascular metastasis from a thyroid cancer

227. The microbiome and human cancer

228. Autophagy

229. ABO Blood Group Incompatibility Protects Against SARS-CoV-2 Transmission

230. Infectious complications in patients treated with immune checkpoint inhibitors

231. Curiethérapie en France en 2020 : synthèse et perspectives du Groupe curiethérapie de la Société française de radiothérapie oncologique

232. Impact of follow-up on generalized pairwise comparisons for estimating the irinotecan benefit in advanced/metastatic gastric cancer

233. Phase II and biomarker study of programmed cell death protein 1 inhibitor nivolumab and metronomic cyclophosphamide in paediatric relapsed/refractory solid tumours: Arm G of AcSé-ESMART, a trial of the European Innovative Therapies for Children With Cancer Consortium

234. HIV-1 Tat Activates Akt/mTORC1 Pathway and AICDA Expression by Downregulating Its Transcriptional Inhibitors in B Cells

235. Prognostic Clinical and Biologic Features for Overall Survival after Relapse in Childhood Medulloblastoma

236. La carence en PBRM1 dans le cancer est létale de synthèse avec les inhibiteurs de réparation de l'ADN

237. PBRM1 deficiency in cancer is synthetic lethal with DNA repair inhibitors

238. Equivalence Randomized Trial to Compare Treatment on the Basis of Sentinel Node Biopsy Versus Neck Node Dissection in Operable T1-T2N0 Oral and Oropharyngeal Cancer

239. mTOR and S6K1 drive polycystic kidney by the control of Afadin-dependent oriented cell division

240. Immunodynamics of explanted human tumors for immuno‐oncology

241. Local anesthetics elicit immune-dependent anticancer effects

242. Together Intra-Tumor Hypoxia and Macrophagic Immunity Are Driven Worst Outcome in Pediatric High-Grade Osteosarcomas

243. A new score based on biomarker values to predict the prognosis of locally advanced cervical cancer

244. Les poly(ADP-Ribose) polymérases 1 et 2 d'Arabidopsis thaliana modifient l'ADN en libérant des résidus terminaux de phosphate

245. La détection des évènements rares

246. BDNF-gene transfected Schwann cells-assisted axonal extension and sprouting on new PLA-PPy microfibre substrates

247. A qualitative evaluation of the use of interventions to treat fatigue among cancer survivors: A healthcare provider’s view

248. Lyl-1 marks and regulates primitive macrophages and microglia development

249. BCG therapy downregulates HLA-I on malignant cells to subvert antitumor immune responses in bladder cancer

250. Toward the creation of an ontology for the coupling of atmospheric electricity with biological systems

Catalog

Books, media, physical & digital resources